EVH:NYE-Evolent Health Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 9.6

Change

-0.26 (-2.64)%

Market Cap

N/A

Volume

1.54M

Analyst Target

USD 11.67
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-12 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+0.03 (+0.04%)

USD 13.01B
DOCS Doximity Inc

+0.24 (+0.32%)

USD 11.03B
WEAV Weave Communications Inc

-0.14 (-0.81%)

USD 1.25B
MPLN MultiPlan Corporation

+3.03 (+12.63%)

USD 0.30B
AMWL American Well Corp

+0.88 (+7.67%)

USD 0.18B
OWLT Owlet Inc

-0.10 (-2.09%)

USD 0.08B
TDOC Teladoc Inc

-0.49 (-3.76%)

N/A
FOXO FOXO Technologies Inc.

N/A

N/A
PHR Phreesia Inc

-0.13 (-0.46%)

N/A
VEEV Veeva Systems Inc Class A

-0.99 (-0.42%)

N/A

ETFs Containing EVH

ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

-0.11 (-0.35%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.67% 18% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.67% 18% F 4% F
Trailing 12 Months  
Capital Gain -68.87% 10% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -68.87% 10% F 1% F
Trailing 5 Years  
Capital Gain -16.23% 50% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.23% 50% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain 37.03% 100% F 90% A-
Dividend Return 37.03% 100% F 89% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 76.19% 50% F 12% F
Risk Adjusted Return 48.60% 90% A- 62% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.